Vincent Lévêque | Co-founder & CEO
Mirava Bio

Day 1 - Tuesday 28 October @ 13:00

Start-ups Pitches

13:00: Dr Mona Boyé, CBDO, Ksilink: Automation and high throughput phenotypic screening of patient-based cellular systems for novel treatment options for rare diseases  

13:05: Dr Boris Sevarika, Co-Founder & CEO, NanoZymeX: Overcoming Limitations of Current Enzyme Replacement Therapies

13:10: Dr William Jang, Head of Global BD, BioMe

13:15: Dr Sumira Riaz, Founder & Health Psychologist, Unboxed Psychology: Applications of behaviour science: Introducing Unboxed Psychology 

13:20: Leonid Stoianov, CEO, Trialize

13:25: Julian Howell, M.D., Founder & CEO, PharmaKrysto: Cystinuria – new approaches to preventing cystine stones – moving to clinical development 

13:30: Fabrice Lejeune, CSO, Genvade Therapeutics: Overcoming the Nonsense in Genetic Diseases

13:35: Dr Alistair Irvine, CEO, Scarlet Therapeutics

13:40: Flaminia Macchia, COO, ORPHANET-AISBL

13:45: Vincent Leveque, Co-Founder & CEO, Mirava Bio: Breaking Barriers: Bringing Rare Disease Therapies to Patients in Europe 

Mona Boyé, CBO, Ksilink

Sumira Riaz, Founder, Health Psychologist & Patient Engagement Consultant, Unboxed Psychology

×

Sumira Riaz / Start-ups Pitches

Sumira Riaz, Founder, Health Psychologist & Patient Engagement Consultant,
Unboxed Psychology

Dr Sumira Riaz (DPsych), Chartered Health Psychologist and Patient Engagement Consultant, Unboxed PsychologyDr Sumira Riaz is a Registered Health Psychologist, Cognitive Behavioural Therapist and Founder of Unboxed Psychology, a behaviour change, patient engagement consultancy. Sumira has 18 years...

CloseMore

Boris Sevarika, Co-Founder and CEO, NanoZymeX

William Jang, Team Member, BioMe, Inc.

×

William Jang / Start-ups Pitches

William Jang, Managing Director of Global Business Development,
BioMe, Inc.

William Jang is a biotechnology executive specializing in the development and global commercialization of microbiome-based therapeutics. He currently serves as Head of Global Business Development at BioMe, Inc., where he drives strategic partnerships, investment initiatives, and regulatory...

CloseMore

Leonid Stoianov, CEO, Trialize

×

Leonid Stoianov / Start-ups Pitches

Leonid Stoianov, CEO,
Trialize

CEO of Trialize. Chairman of HL7 UA. 

Close

Julian Howell, CEO, PharmaKrysto Ltd

×

Julian Howell / Start-ups Pitches

Julian Howell, CEO,
PharmaKrysto Ltd

Julian is the co-founder and leader of PharmaKrysto, a company focused on developing new treatments for people living with rare kidney disease. He has many years of clinical development, translational science and early stage company formation and funding.

Close

Fabrice Lejeune, CSO, Genvade Therapeutics

×

Fabrice Lejeune / Start-ups Pitches

Fabrice Lejeune, CSO,
Genvade Therapeutics

Dr. Fabrice Lejeune is the Scientific Advisor & co-Founder of Genvade Therapeutics. He is the author and inventor of the patents for the lead candidate GV-01 and the drug screening platform. He has been a scientific leader in the search for nonsense mutation correctors for over 20 years. He is...

CloseMore

Alistair Irvine, Chief Executive Officer, Scarlet Therapeutics

×

Alistair Irvine / Start-ups Pitches

Alistair Irvine, Chief Executive Officer,
Scarlet Therapeutics

Alistair Irvine, PhD, joined Scarlet as Founding CEO in August 2022.  He is an experienced biotech and medtech executive who has worked in the industry for >30 years and has broad international executive and R&D experience.  Previous to Scarlet, he was Chief Business Officer at Kuros...

CloseMore

Vincent Lévêque, Co-founder & CEO, Mirava Bio

×

Vincent Lévêque / Start-ups Pitches

Vincent Lévêque, Co-founder & CEO,
Mirava Bio

Vincent Lévêque is a biotech executive with nearly two decades of experience in rare diseases, advanced therapies, and gene therapy commercialization. He has built and led cross-functional organisations across Europe, the Middle East, and Eurasia, with a proven track record of launching...

CloseMore

Flaminia Macchia, Chief Operating Officer, ORPHANET-AISBL

×

Flaminia Macchia / Start-ups Pitches

Flaminia Macchia, Chief Operating Officer,
ORPHANET-AISBL

Flaminia currently serves as the Chief Operating Officer of the Orphanet-AISBL, and as Senior Policy Advisor to different organisations on an independent basis. Flaminia has a broad range of experiences from the patient community, the private sector, as well as the EU institutions. Indeed, Flaminia ...

CloseMore